| # | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. |  ALA4639128 | 62 | pIC50 | = | 4.4 | ALA5303911 | 4.40 | nM | Homo sapiens | |||
| 2. |  GSK620 | 1; 20 | pIC50 | < | 4.3 | ALA5303861 | nM | Homo sapiens | ||||
| 3. |  GSK046 | 15; GSK046 | pIC50 | < | 4.3 | ALA5303812 | nM | Homo sapiens | ||||
| 4. |  MK-8245 | MK-8245 | Activity | 0 | ALA2154722 | Not Active | Homo sapiens | |||||
| 5. | MK-8245 | MK-8245 | Activity | 0 | ALA2154254 | Active | Homo sapiens | |||||
| 6. |  digoxin | Digoxin | Ratio | = | 0.66 | ALA3528696 | Homo sapiens | |||||
| 7. | digoxin | Digoxin | Ratio | = | 0.63 | ALA3528699 | Homo sapiens | |||||
| 8. |  estrone-3-sulphate | estrone-3-O-sulfamate (EMATE) | Ratio | = | 6.7 | ALA3528696 | Homo sapiens | |||||
| 9. |  ALA1496 | Rosuvastatin | Ratio | = | 3.4 | ALA3528696 | Homo sapiens | |||||
| 10. |  midazolam | Midazolam | Ratio | = | 0.92 | ALA3528696 | Homo sapiens | |||||
| 11. | estrone-3-sulphate | estrone-3-O-sulfamate (EMATE) | Ratio | = | 2.2 | ALA3528699 | Homo sapiens | |||||
| 12. | ALA1496 | Rosuvastatin | Ratio | = | 1.9 | ALA3528699 | Homo sapiens | |||||
| 13. | midazolam | Midazolam | Ratio | = | 0.92 | ALA3528699 | Homo sapiens | |||||
| 14. |  Dolutegravir (GSK1349572) | DOLUTEGRAVIR | IC50 | > | 100 | uM | ALA3537109 | nM | Homo sapiens | |||
| 15. |  Paclitaxel | Paclitaxel | IC50 | = | 0.28 | uM | ALA3411291 | 6.55 | nM | Homo sapiens | ||
| 16. |  Vinblastine | Vinblastine | IC50 | = | 46.8 | uM | ALA3411291 | 4.33 | nM | Homo sapiens | ||
| 17. | Paclitaxel | Paclitaxel | INH | = | 16.4 | % | ALA3411295 | % | Homo sapiens | |||
| 18. |  Chlorambucil | chlorambucil (CBL) | Activity | = | 18.8 | % | ALA3411289 | % | Homo sapiens | |||
| 19. |  Cladribine | 25 | Activity | = | 15.9 | % | ALA3411289 | % | Homo sapiens | |||
| 20. |  Irinotecan | Irinotecan | Activity | = | 93.3 | % | ALA3411289 | % | Homo sapiens |
The page will load shortly, Thanks for your patience!